JESSICA AUGERI: Open Payments
NPI 1710491022 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 19 payments from 9 companies in 2025. Trend: 2023 $1,105 · 2024 $789 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $98 |
| QOL Medical, LLC | 3 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Boston Scientific Corporation | 1 | $43 |
| Janssen Biotech, Inc. | 2 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: Sucraid, RINVOQ, ENTYVIO, DUPIXENT, WATCHMAN FLX, TREMFYA, IQIRVO, MAVYRET.
Industry payments across SC — which companies pay providers there.
